Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Jun;124(6):557-65.
doi: 10.1016/j.amjmed.2010.11.032.

Activating peripheral arterial disease patients to reduce cholesterol: a randomized trial

Affiliations
Randomized Controlled Trial

Activating peripheral arterial disease patients to reduce cholesterol: a randomized trial

Mary M McDermott et al. Am J Med. 2011 Jun.

Abstract

Background: Peripheral arterial disease patients are less likely than other high-risk patients to achieve ideal low-density lipoprotein (LDL) cholesterol levels. This randomized controlled trial assessed whether a telephone counseling intervention, designed to help peripheral arterial disease patients request more intensive cholesterol-lowering therapy from their physician, achieved lower LDL cholesterol levels than 2 control conditions.

Methods: There were 355 peripheral arterial disease participants with baseline LDL cholesterol ≥70 mg/dL enrolled. The primary outcome was change in LDL cholesterol level at 12-month follow-up. There were 3 parallel arms: telephone counseling intervention, attention control condition, and usual care. The intervention consisted of patient-centered counseling, delivered every 6 weeks, encouraging participants to request increases in cholesterol-lowering therapy from their physician. The attention control condition consisted of telephone calls every 6 weeks providing information only. The usual care condition participated in baseline and follow-up testing.

Results: At 12-month follow-up, participants in the intervention improved their LDL cholesterol level, compared with those in attention control (-18.4 mg/dL vs -6.8 mg/dL, P=.010) but not compared with those in usual care (-18.4 mg/dL vs -11.1 mg/dL, P=.208). Intervention participants were more likely to start a cholesterol-lowering medication or increase their cholesterol-lowering medication dose than those in the attention control (54% vs 18%, P=.001) and usual care (54% vs 31%, P <.001) conditions.

Conclusion: Telephone counseling that helped peripheral arterial disease patients request more intensive cholesterol-lowering therapy from their physician achieved greater LDL cholesterol decreases than an attention control arm that provided health information alone.

Trial registration: ClinicalTrials.gov NCT00217919.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None

Figures

Figure 1
Figure 1
STUDY PARTICIPATION AND FOLLOW-UP RATES

Comment in

References

    1. Heald CL, Fowkes FG, Murray GD, Price JF. Ankle brachial index collaboration. Atherosclerosis. 2006;189:61–69. - PubMed
    1. Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: A meta-analysis. JAMA. 2008;300:197–208. - PMC - PubMed
    1. Heart Protection Study Collaborative group. MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomized placebo-controlled trial. Lancet. 2002;360:7–22. - PubMed
    1. Waters DD, Brotons C, Chiang CW, et al. Lipid Treatment Assessment Project 2: A multinational survey to evaluate the proportion of patients achieving low density lipoprotein cholesterol goals. Circulation. 2009;120:28–34. - PubMed
    1. McDermott MM, Mehta S, Ahn H, Greenland P. Atherosclerotic risk factors are less intensively modified in peripheral arterial disease than in coronary artery disease. J Gen Intern Med. 1997;12:209–215. - PMC - PubMed

Publication types

Substances

Associated data